Skip to main content
SpringerLink
Log in

Should Antioxidant Vitamins be Routinely Recommended for Older People?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

The hypothesis that oxidative damage due to free radicals is an important cause of aging is the subject of much research and even more interest among the public and lay media. An increasing number of older people are asking whether they should be taking antioxidant vitamins, despite their considerable cost.

Epidemiological and laboratory evidence indicates that oxidative damage caused by oxygen free radicals is important in many of the major diseases of older age. It is also clear that a diet high in antioxidants protects against these diseases, including many cancers and ischaemic heart disease. However, it has not been proven whether antioxidant vitamins, taken as dietary supplements, provide the same level of protection as a diet that is rich in fruit and vegetables. Although there appears to be no reason to discourage older people from taking vitamin E (tocopherols) and ascorbic acid (vitamin C), the best advice to give them is to reduce their intake of xenobiotics, to drink tea instead of coffee, and to eat liberal amounts of fruit, vegetables, nuts, soya beans and lentils. The use of β-carotene as a dietary supplement should be discouraged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harman D. Aging — a theory based on free radical and radiation biology. J Gerontol 1956; 11: 298–300

    Article  PubMed  CAS  Google Scholar 

  2. Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherogenesis. Br Med Bull 1993; 49: 566–76

    PubMed  CAS  Google Scholar 

  3. Comstock GW, Bush TL, Helzsoner K. Serum retinol, beta-carotene, vitamin E and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992; 135: 115–21

    PubMed  CAS  Google Scholar 

  4. Owen AD, Schapira AHV, Jenner P, et al. Oxidative stress and Parkinson’s disease. Ann N Y Acad Sci 1996; 786: 217–23

    Article  PubMed  CAS  Google Scholar 

  5. Harman D. A hypothesis on the pathogenesis of Alzheimer’s disease. Ann N Y Acad Sci 1996; 786: 152–68

    Article  PubMed  CAS  Google Scholar 

  6. Knekt P, Heliovaara M, Rissamen A, et al. Serum antioxidant vitamins and risk of cataract. BMJ 1992; 305: 1392–4

    Article  PubMed  CAS  Google Scholar 

  7. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992; 119: 598–620

    PubMed  CAS  Google Scholar 

  8. Stanton R. Dispelling myths of nutrition: antioxidant theories create confusion. Aust Doctor 1997 Jul 11; 45–6

    Google Scholar 

  9. Harman D. Aging and disease: extending functional life span. Ann N Y Acad Sci 1996; 786: 321–36

    Article  PubMed  CAS  Google Scholar 

  10. Ward JA. Free radicals, antioxidants and preventive geriatrics. Aust Fam Physician 1994; 23: 1297–305

    PubMed  CAS  Google Scholar 

  11. Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford: Clarendon Press, 1985: 11–8

    Google Scholar 

  12. Bland JS. Oxidants and antioxidants in clinical medicine: past, present and future potential. J Nutr Environ Med 1995; 5: 255–80

    Article  CAS  Google Scholar 

  13. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev 1997; 55 (1 Pt 2): S44–52

    Article  PubMed  CAS  Google Scholar 

  14. Jenkins RR, Goldfarb A. Introduction: oxidant stress, aging and exercise. Med Sci Sports Exerc 1993; 25: 210–2

    PubMed  CAS  Google Scholar 

  15. Pacifici RE, Davies KJ. Protein, lipid and DNA repair systems in oxidative stress: the free radical theory of aging revisited. J Gerontol 1991; 37: 166–80

    Article  CAS  Google Scholar 

  16. Schamberger RJ, Andercone TL, Willis CE. Antioxidants and cancer: IV. Initiating activity of malonaldehyde as a carcinogen. J Natl Cancer Inst 1974; 53: 1771–3

    Google Scholar 

  17. Bird RP, Draper HH. Effect of malonaldehyde and acetaldehyde on cultured mammalian cells: growth, morphology and synthesis of macromolecules. J Toxicol Environ Health 1980; 6: 811–23

    Article  PubMed  CAS  Google Scholar 

  18. Sohal RS, editor. Age pigments. Amsterdam: Elsevier, 1981: 303–16

    Google Scholar 

  19. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–23

    Article  PubMed  CAS  Google Scholar 

  20. Diaz MN, Frei B, Vita JA, et al. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337: 408–15

    Article  PubMed  CAS  Google Scholar 

  21. Gaziano JM, Manson JE, Buring JE, et al. Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci 1992; 669: 249–59

    Article  PubMed  CAS  Google Scholar 

  22. Buring JE, Hennekens CH. Antioxidant vitamins and cardiovascular disease. Nutr Reviews 1997; 55 (1 Pt 2): S53–60

    Article  CAS  Google Scholar 

  23. Carew T, Schwenke D, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hypercholesterolemic rabbits. Proc Natl Acad Sci U S A 1987; 84: 7725–9

    Article  PubMed  CAS  Google Scholar 

  24. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444–9

    Article  PubMed  CAS  Google Scholar 

  25. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993; 328: 1450–6

    Article  PubMed  CAS  Google Scholar 

  26. Gazziano JM, Branch LG, Manson JE, et al. Aprospective study of beta-carotene in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol 1995; 5: 255–60

    Article  Google Scholar 

  27. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194–202

    Article  PubMed  CAS  Google Scholar 

  28. Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156–62

    Article  PubMed  CAS  Google Scholar 

  29. Yu BP, Masoro EJ, Murata EJ, et al. Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J Gerontol 1982; 37: 130–41

    Article  PubMed  CAS  Google Scholar 

  30. Ingram DK, Cutler RG, Weindruch R, et al. Dietary restriction and aging: the initiation of a primate study. J Gerontol 1990; 45: B148–63

    Article  PubMed  CAS  Google Scholar 

  31. Harman D. Free radical theory of aging. Mutat Res 1992; 275: 257–66

    Article  PubMed  CAS  Google Scholar 

  32. Blot WJ, Li J-Y, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483–92

    Article  PubMed  CAS  Google Scholar 

  33. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–35

    Google Scholar 

  34. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150–5

    Article  PubMed  CAS  Google Scholar 

  35. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145–9

    Article  PubMed  CAS  Google Scholar 

  36. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781–6

    Article  PubMed  CAS  Google Scholar 

  37. Haeger K, Long-time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 1974; 27: 1179–81

    PubMed  CAS  Google Scholar 

  38. Livingstone PD, Jones C. Treatment of intermittent claudication with vitamin E. Lancet 1958; II: 602–4

    Article  Google Scholar 

  39. Williams HTG, Fenna D, MacBeth RA. Alpha-tocopherol in the treatment of intermittent claudication. Surg Gynecol Obstet 1971; 132: 662–6

    PubMed  CAS  Google Scholar 

  40. Jesberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurochem 1991; 57: 1–17

    Article  CAS  Google Scholar 

  41. Loproscino G, Marder K, Cote L, et al. Dietary lipids and antioxidants in Parkinson’s disease: a population-based, case-control study. Ann Neurol 1996; 39: 89–94

    Article  Google Scholar 

  42. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson’s disease: the Rotterdam Study. Arch Neurol 1997; 54: 762–5

    Article  PubMed  Google Scholar 

  43. The Parkinson’s Study Group. The effect of deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 1989; 321: 1364–71

    Article  Google Scholar 

  44. Fahn S. An open trial of high dose antioxidants in early Parkinson’s disease. Am J Clin Nutr 1991; 53(1 Suppl.): 380S–2S

    PubMed  CAS  Google Scholar 

  45. The Parkinson’s Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 1993; 328: 176–83

    Article  Google Scholar 

  46. Evans DA, Morris MC. Is a randomised trial of antioxidants in the primary prevention of Alzheimer’s disease warranted? Alz Dis Assoc Disord 1996; 10Suppl. 1: 45–9

    Article  CAS  Google Scholar 

  47. Chandra RK. Graying of the immune system: can nutrient supplements improve immunity in the elderly? JAMA 1997; 277: 1398–9

    Article  PubMed  CAS  Google Scholar 

  48. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in-vivo immune response in healthy elderly subjects: a randomised controlled trial. JAMA 1997; 277: 1380–6

    Article  PubMed  CAS  Google Scholar 

  49. Bendick A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988; 48: 612–9

    Google Scholar 

  50. Combs GF. The vitamins: fundamental aspects in nutrition and health. Orlando (FL): Academic Press, 1991: 179–204

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Royal South Sydney Hospital, Joynton Avenue, Zetland, New South Wales, 2017, Australia

    John A. Ward

Authors
  1. John A. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ward, J.A. Should Antioxidant Vitamins be Routinely Recommended for Older People?. Drugs & Aging 12, 169–175 (1998). https://doi.org/10.2165/00002512-199812030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199812030-00001

Keywords

Search

Navigation